Article info

Download PDFPDF
Transdermal fentanyl to parenteral morphine route switch and drug rotation in refractory cancer cachexia

Authors

  • Samy A Alsirafy Palliative Care Service, Hematology-Oncology Department, King Saud Medical City, Riyadh, Saudi ArabiaPalliative Medicine Unit, Kasr Al-Ainy Center of Clinical Oncology & Nuclear Medicine, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt PubMed articlesGoogle scholar articles
  • Saad H Alabdullateef Palliative Care Service, Hematology-Oncology Department, King Saud Medical City, Riyadh, Saudi Arabia PubMed articlesGoogle scholar articles
  • Ashraf M Elyamany Medical Oncology, Hematology-Oncology Department, King Saud Medical City, Riyadh, Saudi ArabiaMedical Oncology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt PubMed articlesGoogle scholar articles
  • Amneh D Hassan Palliative Care Service, Hematology-Oncology Department, King Saud Medical City, Riyadh, Saudi Arabia PubMed articlesGoogle scholar articles
  • Mohammed Almashiakhi Medical Oncology, Hematology-Oncology Department, King Saud Medical City, Riyadh, Saudi Arabia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Samy A Alsirafy, Palliative Medicine Unit, Kasr Al-Ainy Center of Clinical Oncology & Nuclear Medicine, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt; alsirafy{at}kasralainy.edu.eg
View Full Text

Citation

Alsirafy SA, Alabdullateef SH, Elyamany AM, et al
Transdermal fentanyl to parenteral morphine route switch and drug rotation in refractory cancer cachexia

Publication history

  • Received June 19, 2019
  • Accepted August 28, 2019
  • First published September 6, 2019.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.